Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain
NCT: NCT07264920 · NOT_YET_RECRUITING
Brief Summary
This is a study evaluating the Scrambler Therapy device as a non-invasive treatment for neuropathic pain in pediatric oncology patients with metastatic bone disease. The primary goal is to assess changes in pain intensity and medication use, aiming to improve quality of life and reduce reliance on systemic pain medications.
Frequently Asked Questions
What is Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain?
Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain is a clinical trial registered under NCT07264920. Current status: NOT_YET_RECRUITING.
What is the status of NCT07264920?
The current status of NCT07264920 (Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain) is: NOT_YET_RECRUITING.
When did Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain start?
Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain started on 2026-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.